Chongqing Shangrenyu Pharmaceutical Co., Ltd.

Luoxin Pharmaceutical Group Joint-stock Co., Ltd. (stock code: 002793) is a large pharmaceutical enterprise group integrating drug research and development, production, trade, and medical and health services. Since 2006, the company has continuously ranked among China's top 100 pharmaceutical industrial enterprises. Since 2011, it has been continuously rated as an excellent industrial enterprise in China's pharmaceutical R&D product line. It is a national industrial quality benchmark enterprise, a national key high-tech enterprise, and a national technological innovation demonstration enterprise. Adhering to the strategic policy of "revitalizing the enterprise through science and technology," the company has established a scientific research center in Zhangjiang High-Tech Park, Shanghai. A scientific research team composed of high-end scientific and technological talents from home and abroad, leveraging various advantageous resources in Zhangjiang High-Tech Park, undertakes the research and development of the group's high-tech projects and the cultivation of high-tech talents. Together with the headquarters, it has formed a trinity scientific research system, more powerfully promoting the development of new drugs. The company has a national recognized enterprise technology center, a national-local joint engineering laboratory, a national postdoctoral research workstation, a "Taishan Scholar - Pharmacy Distinguished Expert" position, a Shandong Provincial Enterprise Academician Workstation, a Shandong Provincial Lyophilized Powder Injection Drug Engineering Technology Research Center, a Shandong Provincial Lyophilized Powder Injection Drug Engineering Laboratory, and a Shandong Provincial Lyophilized Powder Injection Drug Key Laboratory. At Shenyang Pharmaceutical University, Luoxin Pharmaceutical has established a postdoctoral mobile workstation, a teaching and training base, an internship base, and a graduate employment base, forming a strong scientific research and technology center and injecting vitality into the rapid development of the enterprise. The group's 18 products have been included in the national "Major New Drug Creation" science and technology major special project; 4 products have been included in the "National Key New Product Plan"; 12 products have been included in the "National Torch Plan"; 144 projects have been included in the Shandong Provincial Torch Plan, Shandong Provincial Science and Technology Development Plan, and Shandong Provincial Technological Innovation Projects. Multiple products have won the "Science and Technology Progress Award," among which one product technology won the second prize of the National Science and Technology Progress Award. More than 200 product technologies have obtained Chinese invention patent certificates, with patent protection for 20 years. Luoxin Group adheres to the guiding ideology of integrity-based and pioneering innovation, and the values of "repaying employees, repaying customers, repaying shareholders, repaying society, and strengthening the enterprise," continuously creating the greatest value space needed by customers, and adhering to serving customers with high-quality products, favorable prices, and excellent service. Luoxin Group is willing to join hands with colleagues in the pharmaceutical industry to advance together, deliver health, and create brilliance together.